Centessa Prescription drugs’ cleminorexton is a part of the orexin agonist drug class, which might introduce a brand new method to the therapy of narcolepsy and different sleep issues. Buying Centessa brings Eli Lilly into a gaggle of clinical-stage orexin agonist drug builders that features Takeda Pharmaceutical, Alkermes, and Eisai.
The submit Eli Lilly’s Neuro Prospects Develop to Sleep Science With $6.3B Centessa Acquisition appeared first on MedCity Information.
